Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Thrombosis Research|May 12, 2026
Human iPSC-derived platelets generated in alginate scaffolds exhibit functional haemostasis in vitro and in vivoMarina Tarunina, Richard Amison, Tatyana Ponomaryov, et al.Pulmonary Pharmacology & Therapeutics|June 5, 2025
A novel macrolide, EP395, with reduced antibacterial activity and an enhancing effect on respiratory epithelial barrierThorarinn Gudjonsson, Jon Petur Joelsson, Ari Jon Arason, et al.Pulmonary Pharmacology & Therapeutics|March 29, 2023
Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot studyGilberto DeNucci, Tom Wilkinson, Carlos Sverdloff, et al.Critical Care (London, England)|July 24, 2020
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidenceFrank M P van Haren, Clive Page, John G Laffey, et al.Pulmonary Pharmacology & Therapeutics|August 21, 2007
The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot studyNicola A Hanania, Supria Singh, Rami El-Wali, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 17, 2016
Lung inflammation does not affect the clearance kinetics of lipid nanocapsules following pulmonary administrationAateka Patel, A Woods, Yanira Riffo-Vasquez, et al.Nanotoxicology|March 14, 2014
Adenosine monophosphate is elevated in the bronchoalveolar lavage fluid of mice with acute respiratory toxicity induced by nanoparticles with high surface hydrophobicityLea Ann Dailey, Raquel Hernández-Prieto, Ana Maria Casas-Ferreira, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine systemZoë Johnson, Marie H Kosco-Vilbois, Suzanne Herren, et al.Mabs|June 9, 2016
Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, FranceGuillaume Desoubeaux, Janice M Reichert, Matthew Sleeman, et al.The Journal of Pharmacology and Experimental Therapeutics|December 14, 2011
Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthmaChristopher A Hewson, Sheena Patel, Luigino Calzetta, et al.Pageof 10